General Information
Edoxaban is an anti-clotting substance indicated to reduce the risk of stroke and systemic embolism (blood coagulation) in patients with nonvalvular atrial fibrillation (abnormal heart rhythm that is not caused by a heart valve problem).
About the API
Technology
Synthetic
Molecular Formula
C31H38ClN7O7S2
Molecular Weight
720.3 g/mol
Therapeutic category
Coagulation Inhibitors
Available formulations
Oral Solid
Regulations
Canada DMF
Canada DMF